ATE423218T1 - Komponenten des ampk-wegs - Google Patents

Komponenten des ampk-wegs

Info

Publication number
ATE423218T1
ATE423218T1 AT03812515T AT03812515T ATE423218T1 AT E423218 T1 ATE423218 T1 AT E423218T1 AT 03812515 T AT03812515 T AT 03812515T AT 03812515 T AT03812515 T AT 03812515T AT E423218 T1 ATE423218 T1 AT E423218T1
Authority
AT
Austria
Prior art keywords
ampk
alter
activity
path
components
Prior art date
Application number
AT03812515T
Other languages
English (en)
Inventor
Javier Apfeld
Greg O'connor
Original Assignee
Elixir Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elixir Pharmaceuticals Inc filed Critical Elixir Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE423218T1 publication Critical patent/ATE423218T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
AT03812515T 2002-12-04 2003-12-04 Komponenten des ampk-wegs ATE423218T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43080402P 2002-12-04 2002-12-04
US48826103P 2003-07-18 2003-07-18

Publications (1)

Publication Number Publication Date
ATE423218T1 true ATE423218T1 (de) 2009-03-15

Family

ID=32474596

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03812515T ATE423218T1 (de) 2002-12-04 2003-12-04 Komponenten des ampk-wegs

Country Status (6)

Country Link
EP (1) EP1576180B1 (de)
AT (1) ATE423218T1 (de)
AU (1) AU2003300818A1 (de)
CA (1) CA2508236A1 (de)
DE (1) DE60326272D1 (de)
WO (1) WO2004050898A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007044622A1 (en) * 2005-10-07 2007-04-19 Yale University Use of mif and mif pathway agonists
US20090042810A1 (en) * 2007-04-27 2009-02-12 Genexel-Sein, Inc. AMPK Deficient Animals, Screening Methods, And Related Therapeutics And Diagnostics
GB0715284D0 (en) * 2007-08-06 2007-09-12 Medical Res Council Crystal structure of ampk and uses thereof
US9817001B2 (en) 2008-05-27 2017-11-14 Boston Heart Diagnostics Corporation Methods for determining LDL cholesterol treatment
WO2010005303A2 (en) * 2008-07-07 2010-01-14 Publiekrechtelijke Rechtspersoon Academisch Ziekenhuis Leiden H.O.D.N. Leids Universitair Medisch Centrum New indicators of human longevity and biological ageing rate
US8470541B1 (en) 2008-09-27 2013-06-25 Boston Heart Diagnostics Corporation Methods for separation and immuno-detection of biomolecules, and apparatus related thereto
WO2010151880A2 (en) * 2009-06-26 2010-12-29 The Salk Institute For Biological Studies Increasing lifespan by modulating crtc expression or localization, and methods of screening for modulators of same
US8765377B2 (en) 2011-10-13 2014-07-01 Boston Heart Diagnostics Corporation Compositions and methods for treating and preventing coronary heart disease
WO2014180908A1 (en) * 2013-05-08 2014-11-13 Deutsches Krebsforschungszentrum Acip/peptide-based inhibition of cancer cachexia
US9828624B2 (en) 2013-07-24 2017-11-28 Boston Heart Diagnostics Corporation Driving patient compliance with therapy
EP3220810A4 (de) 2014-11-17 2018-05-16 Boston Heart Diagnostic Corporation Beurteilung des risikos für herz-kreislauf-erkrankungen
WO2020214936A1 (en) * 2019-04-17 2020-10-22 University Of Houston System Methods of improving the longevity of immune cells
CN115261355B (zh) * 2022-09-14 2023-07-28 广东医科大学 AMPKα1琥珀酰化修饰及应用

Also Published As

Publication number Publication date
AU2003300818A1 (en) 2004-06-23
CA2508236A1 (en) 2004-06-17
EP1576180A2 (de) 2005-09-21
WO2004050898A2 (en) 2004-06-17
EP1576180A4 (de) 2006-08-02
EP1576180B1 (de) 2009-02-18
WO2004050898A3 (en) 2005-11-10
DE60326272D1 (de) 2009-04-02

Similar Documents

Publication Publication Date Title
ATE423218T1 (de) Komponenten des ampk-wegs
CY1119509T1 (el) Συνθεσεις και μεθοδοι για ρυθμιστες αποπτωσης
WO2006088972A3 (en) Use of modulatirs of compounds of tgf-beta superfamily to regulate hepcidin-mediated iron metabolism
JO2872B1 (en) New vehicles
MX2010002712A (es) Compuestos que modulan calcio intracelular.
SV2009003235A (es) Triazoles biciclicos como moduladores de la proteina cinasa ref. x-18476m
NO20084792L (no) Substituerte imidazol-4-karboksamider som kolecystokinin-1-reseptormodulatorer
CY1113975T1 (el) Παραγοντες για προληψη και θεραπεια διαταραχων που περιλαμβανουν διαφοροποιηση των υποδοχεων ryr
MY162157A (en) Substituted indole mcl-1 inhibitors
ATE400319T1 (de) Tetrahydropyridothiophene
WO2006002387A3 (en) Gdf3 propeptides and related methods
ATE473004T1 (de) Substituierte imidazol-4-carboxamide als cholecystokinin-1-rezeptor-modulatoren
EA201001330A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
Holmes Trophic mechanisms for exercise-induced stress resilience: potential role of interactions between BDNF and galanin
ATE479435T1 (de) Substituierte imidazol-4-carboxamide als cholecystokinin-1-rezeptor-modulatoren
ZA200606840B (en) Use of TWEAK modulators and inhibitors for the treatment of neurological conditions
DK1565422T3 (da) Vitamin-D-receptor-modulatorer
Paul Cysteine metabolism and hydrogen sulfide signaling in Huntington’s disease
NO20080061L (no) Imidazolyl-pyrimidinforbindelser for anvendelse til behandling av proliferative lidelser
CR9057A (es) Compuestos aromaticos de arilsulfonilmetil o arilsilfonamida sustituida apropiados para tratar trastornos que responden a la modulacion del receptor de dopamina d3
BRPI0606621A2 (pt) gene e proteìna de percepção de açucar regulados por nitrogênio e modulação dos mesmos
ATE489628T1 (de) Galk1s als modifikatoren des pten/akt-wegs
EP1713935A4 (de) Modulation einer hsv-infektion
ATE536549T1 (de) Galnts als modifikatoren des igfr-weges und verwendungsverfahren
DE602005025737D1 (de) C20orf23 als modifikator des igfr-wegs und verwendungsverfahren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties